Serum periostin levels in mycosis fungoides: associations with clinical subtype and disease stage
Dermatology Reports · 31.07.2026
DOI: 10.4081/dr.2026.10904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Reports, online erschienen am 31.07.2026. Verfasst von Ramazan Çetin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Ondokuz Mayıs University, Samsun. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Serum biomarkers with diagnostic and staging relevance in mycosis fungoides (MF) remain limited. In this prospective case-control study, we evaluated serum periostin levels in 40 patients with MF and 40 matched healthy controls, and assessed their associations with clinical subtype and disease stage. Serum periostin was measured by enzyme-linked immunosorbent assay (ELISA), and comparisons were performed using non-parametric tests. Serum periostin levels were significantly higher in patients with MF than in controls (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine, Ondokuz Mayıs University, Samsun.
ORCID-Profile: Ramazan Çetin
Zitieren
APA
Çetin, R., & Güler Özden, M. (2026). Serum periostin levels in mycosis fungoides: associations with clinical subtype and disease stage. Dermatology Reports. https://doi.org/10.4081/dr.2026.10904
Vancouver
Çetin R, Güler Özden M. Serum periostin levels in mycosis fungoides: associations with clinical subtype and disease stage. Dermatology Reports. 2026. doi:10.4081/dr.2026.10904
BibTeX
@article{etin2026,
author = {Çetin, Ramazan and Güler Özden, Müge},
title = {Serum periostin levels in mycosis fungoides: associations with clinical subtype and disease stage},
journal = {Dermatology Reports},
year = {2026},
doi = {10.4081/dr.2026.10904}
}
EUVIMED